ClinCalc Pro
Menu
Medical Device / Topical Scar Treatment Pregnancy: Safe for topical use — no systemic absorption.

Silicone Gel / Sheeting (Scar Management)

Brand names: Mepiform, Cica-Care, Dermatix, NewGel+E

Adult dose

Dose: Silicone gel: apply thin layer to healed wound twice daily; silicone sheeting: apply for 12–24 hours/day; commence once epithelialisation complete and wound fully healed
Route: Topical
Frequency: Twice daily (gel) or continuously (sheeting — minimum 12 hours/day)
Max: Continuous use for 3–6 months minimum (scar maturation period)
First-line non-invasive scar treatment in burns — British Burns Association and NICE recommend as initial treatment for established/developing hypertrophic scars and keloids. Mechanism: hydration, temperature increase, and static electricity reduce collagen synthesis. Most effective when started early (2 weeks post-healing) and used consistently.

Paediatric dose

Route:
Frequency: 12–24 hours/day (sheeting); twice daily (gel)
Max: As per adult schedule
Safe in all paediatric age groups — commence as soon as wound is fully re-epithelialised. Paediatric burns scar treatment: silicone gel + compression garment combination is BBA standard of care.

Dose adjustments

Renal

Not applicable — topical use only.

Hepatic

Not applicable.

Clinical pearls

  • BBA Scar Management Guidelines 2019: silicone therapy is Grade A evidence for hypertrophic scar prevention and treatment. Commence within 2 weeks of wound healing; use for minimum 3–6 months. Combine with compression garment (24–23 mmHg pressure) for burns covering joint surfaces
  • Keloid vs hypertrophic scar distinction: hypertrophic scars remain within wound boundaries and may spontaneously regress; keloids extend beyond wound margins and rarely regress without treatment. Silicone effective for hypertrophic — less effective for established keloids which require additional intralesional therapy (triamcinolone, bleomycin, 5-FU, verapamil)
  • Adherence is critical: 12–24 hours/day wear for 3–6 months is required for efficacy; poor adherence (common) leads to treatment failure. Silicone sheets can be washed and reused for 2–3 months before replacing. Gel formulation preferred for facial areas, joints, and paediatric patients

Contraindications

  • Open or incompletely healed wounds (risk of maceration and delayed healing)
  • Active infection at application site
  • Known silicone allergy (rare)

Side effects

  • Skin maceration (if wound not fully healed)
  • Pruritus at application site
  • Contact dermatitis (uncommon)
  • Folliculitis (under sheeting — ensure daily cleaning)
  • Malodour under sheeting (poor hygiene)

Interactions

  • No pharmacological interactions — topical medical device

Monitoring

  • Scar assessment (Vancouver Scar Scale or Patient and Observer Scar Assessment Scale — POSAS)
  • Wound integrity under sheeting (daily skin check)
  • Adherence to daily wear schedule
  • Signs of contact dermatitis or folliculitis

Reference: BNFc; British Burns Association Scar Management Guidelines 2019; NICE NG24 (Burns); Mustoe et al. Plast Reconstr Surg 2002 (International Advisory Panel on Scar Management); BNFc. Verify against your local formulary and the latest BNF before prescribing.

Related

Curated clinical cross-links plus same-class fallbacks.